AIC
IMVT icon

AWM Investment Company’s Immunovant IMVT Stock Holding History

AWM Investment Company’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25,000
Closed -$713K – 91
2024
Q3 		$713K Sell
25,000
-25,000
-50% -$737K 0.09% 86
2024
Q2 		$1.32M Sell
50,000
-20,000
-29% -$569K 0.18% 77
2024
Q1 		$2.26M Hold
70,000
– – 0.3% 68
2023
Q4 		$2.95M Buy
70,000
+20,000
+40% +$736K 0.39% 58
2023
Q3 		$1.92M Buy
+50,000
New +$1.13M 0.28% 68

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

AWM Investment Company's IMVT Position: Q4 2024 in Review

AWM Investment Company sold out of Immunovant (IMVT) in Q4 2024, closing a stake of 25,000 shares — an estimated $713K sold.

AWM Investment Company first reported a position in IMVT in Q3 2023 and held it in 5 quarters. The position peaked at $2.95M in Q4 2023. 186 funds tracked by Wall St. Rank hold IMVT as of Q4 2024.

  • AWM Investment Company reported no remaining Immunovant position as of Q4 2024 after selling out during the quarter.
  • AWM Investment Company sold 25,000 Immunovant shares in Q4 2024, an estimated $713K.
  • AWM Investment Company first reported a position in Immunovant in Q3 2023 and held it in 5 quarters.
  • AWM Investment Company's Immunovant position peaked at $2.95M in Q4 2023.
  • 186 funds tracked by Wall St. Rank held Immunovant as of Q4 2024.

Based on AWM Investment Company's 13F filing for Q4 2024, filed 18 Feb 2025.